Wilson Sonsini Goodrich & Rosati acted as Concord Healthcare’s U.S. and Hong Kong counsel in the IPO and SEHK listing. Concord Medical Services Holdings Limited (“Concord...
Concord Healthcare’s $72.2 Million Initial Public Offering
ZX Inc.’s HK$266 Million Hong Kong IPO
Kirkland & Ellis, Beijing Dacheng Law Offices, LLP, Goldsun Law Firm and Walkers (Hong Kong) represented ZX Inc., and Wilson Sonsini Goodrich & Rosati and JunHe...
Edianyun Limited’s Hong Kong IPO
Harneys acted as Cayman Islands counsel to Edianyun Limited on the transaction, while Wilson Sonsini Goodrich & Rosati acted as U.S. and Hong Kong counsel to...
Luzhu Biotechnology’s US$43.4 Million IPO
Wilson Sonsini Goodrich & Rosati acted as U.S. and Hong Kong counsel to the sole sponsor (China International Capital Corporation Hong Kong Securities Limited) and the...
Fenbi’s HK$198 Million Listing on The HKSE
Cooley advised the underwriters involved in the listing while Wilson Sonsini Goodrich & Rosati represented Fenbi. Fenbi, an internet-born test preparation company, proposed the listing of...
Huafang Group Inc.’s IPO
O’Melveny advised the sponsors and underwriters on the listing, while Wilson Sonsini Goodrich & Rosati and Maples and Calder represented Huafang. Huafang Group Inc. announced the IPO...
Zibuyu Group Limited’s HK$197.7 Million IPO
Harneys acted as Cayman Islands counsel to Zibuyu Group Limited on the listing. Tian Yuan Law Firm LLP provided Hong Kong legal advice to Zibuyu and...
LEPU ScienTech Medical Technology (Shanghai) Co., Ltd.’s Listing on the Main Board of the Hong Kong Stock Exchange
Herbert Smith Freehills has advised China International Capital Corporation as the sole sponsor on the listing of LEPU ScienTech Medical Technology while Wilson Sonsini Goodrich &...